NasdaqGS - Nasdaq Real Time Price USD

Nautilus Biotechnology, Inc. (NAUT)

0.8816
-0.0454
(-4.90%)
At close: May 14 at 4:00:01 PM EDT
All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-56,816
-59,145
-51,711
-45,806
-39,241
Investing Cash Flow
63,408
66,250
-43,735
-25,740
-138,964
Financing Cash Flow
917
1,144
368
562
327,447
End Cash Position
34,240
28,648
20,399
115,477
186,461
Capital Expenditure
-1,694
-2,122
-2,442
-2,324
-2,269
Issuance of Capital Stock
--
--
--
--
0
Free Cash Flow
-58,510
-61,267
-54,153
-48,130
-41,510
12/31/2021 - 8/7/2020

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

SEER Seer, Inc.
2.1100
+9.90%
 
PROK ProKidney Corp.
0.7711
-11.20%
 
LYEL Lyell Immunopharma, Inc.
0.3900
-3.61%
 
ALEC Alector, Inc.
1.0700
-3.60%
 
DNTH Dianthus Therapeutics, Inc.
18.90
+0.32%
 
LENZ LENZ Therapeutics, Inc.
27.63
-4.59%
 
RLYB Rallybio Corporation
0.3095
+3.86%
 
PMN ProMIS Neurosciences, Inc.
0.5050
-2.88%
 
CELU Celularity Inc.
2.0200
+8.02%
 
ERAS Erasca, Inc.
1.2700
-4.51%